相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial
Raffael Nachbagauer et al.
NATURE MEDICINE (2021)
A Strategy to Elicit M2e-Specific Antibodies Using a Recombinant H7N9 Live Attenuated Influenza Vaccine Expressing Multiple M2e Tandem Repeats
Daria Mezhenskaya et al.
BIOMEDICINES (2021)
Development and Evaluation of an Ebola Virus Glycoprotein Mucin-Like Domain Replacement System as a New Dendritic Cell-Targeting Vaccine Approach against HIV-1
Zhujun Ao et al.
JOURNAL OF VIROLOGY (2021)
A single dose of a vesicular stomatitis virus-based influenza vaccine confers rapid protection against H5 viruses from different clades
Wakako Furuyama et al.
NPJ VACCINES (2020)
IgA Responses Following Recurrent Influenza Virus Vaccination
Rodrigo B. Abreu et al.
FRONTIERS IN IMMUNOLOGY (2020)
Self-Assembly M2e-Based Peptide Nanovaccine Confers Broad Protection Against Influenza Viruses
Qimin Wang et al.
FRONTIERS IN MICROBIOLOGY (2020)
A year of terror and a century of reflection: perspectives on the great influenza pandemic of 1918-1919
Michaela E. Nickol et al.
BMC INFECTIOUS DISEASES (2019)
Back to the Future for Influenza PreimmunityLooking Back at Influenza Virus History to Infer the Outcome of Future Infections
Magen Ellen Francis et al.
VIRUSES-BASEL (2019)
Incorporation of Ebola glycoprotein into HIV particles facilitates dendritic cell and macrophage targeting and enhances HIV-specific immune responses
Zhujun Ao et al.
PLOS ONE (2019)
Influenza and Antibody-Dependent Cellular Cytotoxicity
Tarra A. Von Holle et al.
FRONTIERS IN IMMUNOLOGY (2019)
Recombinant vesicular stomatitis virus vector vaccines for WHO blueprint priority pathogens
Anahita Fathi et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2019)
Dendritic Cells/Macrophages-Targeting Feature of Ebola Glycoprotein and its Potential as Immunological Facilitator for Antiviral Vaccine Approach
Titus Abiola Olukitibi et al.
MICROORGANISMS (2019)
Spec-seq unveils transcriptional subpopulations of antibody-secreting cells following influenza vaccination
Karlynn E. Neu et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
M2e-based universal influenza vaccines: a historical overview and new approaches to development
Daria Mezhenskaya et al.
JOURNAL OF BIOMEDICAL SCIENCE (2019)
The human antibody response to influenza A virus infection and vaccination
Florian Krammer
NATURE REVIEWS IMMUNOLOGY (2019)
Comprehending a Killer: The Akt/mTOR Signaling Pathways Are Temporally High-Jacked by the Highly Pathogenic 1918 Influenza Virus
Charlene Ranadheera et al.
EBIOMEDICINE (2018)
Combination of M2e peptide with stalk HA epitopes of influenza A virus enhances protective properties of recombinant vaccine
Liudmila M. Tsybalova et al.
PLOS ONE (2018)
Back to the Future: Lessons Learned From the 1918 Influenza Pandemic
Kirsty R. Short et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2018)
Targeting Influenza Virus Hemagglutinin to Xcr1+ Dendritic Cells in the Absence of Receptor-Mediated Endocytosis Enhances Protective Antibody Responses
Arnar Gudjonsson et al.
JOURNAL OF IMMUNOLOGY (2017)
Psychological factors associated with uptake of the childhood influenza vaccine and perception of post-vaccination side-effects: A cross-sectional survey in England
Louise E. Smith et al.
VACCINE (2017)
Strong Clonal Relatedness between Serum and Gut IgA despite Different Plasma Cell Origins
Rasmus Iversen et al.
CELL REPORTS (2017)
Psychological determinants of influenza vaccination
Jens-Oliver Bock et al.
BMC GERIATRICS (2017)
Ebola Virus Glycoprotein Induces an Innate Immune Response In vivo via TLR4
Chih-Yun Lai et al.
FRONTIERS IN MICROBIOLOGY (2017)
Enhancing vaccine antibody responses by targeting Clec9A on dendritic cells
Hae-Young Park et al.
NPJ VACCINES (2017)
Increasing Vaccination: Putting Psychological Science Into Action
Noel T. Brewer et al.
PSYCHOLOGICAL SCIENCE IN THE PUBLIC INTEREST (2017)
Characterization of the single cycle replication of HIV-1 expressing Gaussia luciferase in human PBMCs, macrophages, and in CD4+ T cell-grafted nude mouse
Zhujun Ao et al.
JOURNAL OF VIROLOGICAL METHODS (2016)
Influenza Virus Hemagglutinin Glycoproteins with Different N-Glycan Patterns Activate Dendritic Cells In Vitro
Wen-Chun Liu et al.
JOURNAL OF VIROLOGY (2016)
Universal influenza vaccines: Shifting to better vaccines
Francesco Berlanda Scorza et al.
VACCINE (2016)
Broadly Neutralizing Hemagglutinin Stalk-Specific Antibodies Induce Potent Phagocytosis of Immune Complexes by Neutrophils in an Fc-Dependent Manner
Caitlin E. Mullarkey et al.
MBIO (2016)
Stalking influenza by vaccination with pre-fusion headless HA mini-stem
Sophie A. Valkenburg et al.
SCIENTIFIC REPORTS (2016)
In vivo dendritic cell targeting cellular vaccine induces CD4+ Tfh cell-dependent antibody against influenza virus
Satoru Yamasaki et al.
SCIENTIFIC REPORTS (2016)
Spatial Localization of the Ebola Virus Glycoprotein Mucin-Like Domain Determined by Cryo-Electron Tomography
Erin E. H. Tran et al.
JOURNAL OF VIROLOGY (2014)
Flow Cytometry Reveals that H5N1 Vaccination Elicits Cross-Reactive Stem-Directed Antibodies from Multiple Ig Heavy-Chain Lineages
James R. R. Whittle et al.
JOURNAL OF VIROLOGY (2014)
Safety and immunogenicity of a plant-produced recombinant monomer hemagglutinin-based influenza vaccine derived from influenza A (H1N1)pdm09 virus: A Phase 1 dose-escalation study in healthy adults
James F. Cummings et al.
VACCINE (2014)
Ebola Virus Exploits a Monocyte Differentiation Program To Promote Its Entry
Osvaldo Martinez et al.
JOURNAL OF VIROLOGY (2013)
Virus-like Particles Containing Multiple M2 Extracellular Domains Confer Improved Cross-protection Against Various Subtypes of Influenza Virus
Min-Chul Kim et al.
MOLECULAR THERAPY (2013)
Analytical technologies for influenza virus-like particle candidate vaccines: challenges and emerging approaches
Christine M. Thompson et al.
VIROLOGY JOURNAL (2013)
Influenza virus hemagglutinin stalk-based antibodies and vaccines
Florian Krammer et al.
CURRENT OPINION IN VIROLOGY (2013)
New World Bats Harbor Diverse Influenza A Viruses
Suxiang Tong et al.
PLOS PATHOGENS (2013)
The role of antigen-presenting cells in filoviral hemorrhagic fever: Gaps in current knowledge
Osvaldo Martinez et al.
ANTIVIRAL RESEARCH (2012)
The role of nasal IgA in children vaccinated with live attenuated influenza vaccine
Christopher S. Ambrose et al.
VACCINE (2012)
Recombinant Vesicular Stomatitis Virus-Based Vaccines Against Ebola and Marburg Virus Infections
Thomas W. Geisbert et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Safety and immunogenicity of a recombinant M2e-flagellin influenza vaccine (STF2.4xM2e) in healthy adults
Christine B. Turley et al.
VACCINE (2011)
Characterization of a trypsin-dependent avian influenza H5N1-pseudotyped HIV vector system for high throughput screening of inhibitory molecules
Zhujun Ao et al.
ANTIVIRAL RESEARCH (2008)
Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor
Jeffrey E. Lee et al.
NATURE (2008)
Epitopes required for antibody-dependent enhancement of Ebola virus infection
Ayato Takada et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Ebola virus-like particles produced in insect cells exhibit dendritic cell stimulating activity and induce neutralizing antibodies
Ling Ye et al.
VIROLOGY (2006)
Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity
T Querec et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Contribution of the C-terminal tri-lysine regions of human immunodeficiency virus type 1 integrase for efficient reverse transcription and viral DNA nuclear import
ZJ Ao et al.
RETROVIROLOGY (2005)
Dendritic cells as therapeutic vaccines against cancer
J Banchereau et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Sequence comparison between the extracellular domain of M2 protein human and avian influenza A virus provides new information for bivalent influenza vaccine design
WL Liu et al.
MICROBES AND INFECTION (2005)
Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine
RB Belshe et al.
JOURNAL OF INFECTIOUS DISEASES (2000)